Published in Am J Clin Nutr on January 13, 2010
Suppression of intestinal inflammation and inflammation-driven colon cancer in mice by dietary sphingomyelin: importance of peroxisome proliferator-activated receptor γ expression. J Nutr Biochem (2011) 0.85
Egg phospholipids and cardiovascular health. Nutrients (2015) 0.83
Metabolism, physiological role, and clinical implications of sphingolipids in gastrointestinal tract. Biomed Res Int (2013) 0.82
Regulation of cytoskeleton organization by sphingosine in a mouse cell model of progressive ovarian cancer. Biomolecules (2013) 0.79
Effect of dietary sphingomyelin on absorption and fractional synthetic rate of cholesterol and serum lipid profile in humans. Lipids Health Dis (2013) 0.77
Changes of activity and isoforms of alkaline sphingomyelinase (nucleotide pyrophosphatase phosphodiesterase 7) in bile from patients undergoing endoscopic retrograde cholangiopancreatography. BMC Gastroenterol (2014) 0.75
Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join Forces. Mediators Inflamm (2016) 0.75
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology (2005) 5.92
Absorption and lipoprotein transport of sphingomyelin. J Lipid Res (2005) 1.38
Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family. J Biol Chem (2003) 1.28
Zebrafish: gaining popularity in lipid research. Biochem J (2010) 1.23
Inhibition of cancer cell proliferation in vitro by fruit and berry extracts and correlations with antioxidant levels. J Agric Food Chem (2004) 1.23
Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells. Carcinogenesis (2002) 1.20
Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development. Prog Lipid Res (2008) 1.11
Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway. Int J Mol Med (2002) 1.01
Intra-individual variations and time trends 1991-2001 in human serum levels of PCB, DDE and hexachlorobenzene. Chemosphere (2006) 1.00
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study. Inflamm Bowel Dis (2011) 1.00
Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity. Inflamm Bowel Dis (2002) 0.97
Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-kappaB in macrophages. Inflamm Res (2009) 0.96
Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity. Biochem J (2006) 0.95
Pancreatic trypsin cleaves intestinal alkaline sphingomyelinase from mucosa and enhances the sphingomyelinase activity. Am J Physiol Gastrointest Liver Physiol (2004) 0.95
LY294002 enhances boswellic acid-induced apoptosis in colon cancer cells. Anticancer Res (2009) 0.94
Identification of one exon deletion of intestinal alkaline sphingomyelinase in colon cancer HT-29 cells and a differentiation-related expression of the wild-type enzyme in Caco-2 cells. Carcinogenesis (2004) 0.94
Purification, localization, and expression of human intestinal alkaline sphingomyelinase. J Lipid Res (2003) 0.94
Ursolic acid inhibits proliferation and stimulates apoptosis in HT29 cells following activation of alkaline sphingomyelinase. Anticancer Res (2003) 0.92
Identification of two novel sequence variants affecting thiopurine methyltransferase enzyme activity. Pharmacogenetics (2004) 0.92
Arachidonic acid and ischemic heart disease. J Nutr (2005) 0.91
Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression. Lipids Health Dis (2010) 0.91
Comparison of the 2,2'-azinobis-3-ethylbenzotiazo-line-6-sulfonic acid (ABTS) and ferric reducing anti-oxidant power (FRAP) methods to asses the total antioxidant capacity in extracts of fruit and vegetables. Mol Nutr Food Res (2005) 0.90
Crucial role of alkaline sphingomyelinase in sphingomyelin digestion: a study on enzyme knockout mice. J Lipid Res (2010) 0.89
Purification and characterization of human intestinal neutral ceramidase. Biochimie (2007) 0.89
Functional studies of human intestinal alkaline sphingomyelinase by deglycosylation and mutagenesis. Biochem J (2005) 0.89
Purified intestinal alkaline sphingomyelinase inhibits proliferation without inducing apoptosis in HT-29 colon carcinoma cells. J Cancer Res Clin Oncol (2003) 0.87
Degree of in vivo inhibition of human gastric and pancreatic lipases by Orlistat (Tetrahydrolipstatin, THL) in the stomach and small intestine. Clin Nutr (2002) 0.87
Ursolic acid inhibits the formation of aberrant crypt foci and affects colonic sphingomyelin hydrolyzing enzymes in azoxymethane-treated rats. J Cancer Res Clin Oncol (2007) 0.86
Curcumin decreases acid sphingomyelinase activity in colon cancer Caco-2 cells. Planta Med (2007) 0.86
Long term effects on human plasma lipoproteins of a formulation enriched in butter milk polar lipid. Lipids Health Dis (2009) 0.86
Expression of alkaline sphingomyelinase in yeast cells and anti-inflammatory effects of the expressed enzyme in a rat colitis model. Dig Dis Sci (2008) 0.85
Understanding the molecular activity of alkaline sphingomyelinase (NPP7) by computer modeling. Biochemistry (2010) 0.84
Generating ceramide from sphingomyelin by alkaline sphingomyelinase in the gut enhances sphingomyelin-induced inhibition of cholesterol uptake in Caco-2 cells. Dig Dis Sci (2010) 0.84
Characterization of a novel sequence variant, TPMT*28, in the human thiopurine methyltransferase gene. Pharmacogenet Genomics (2010) 0.84
Quantitative role of plasma free fatty acids in the supply of arachidonic acid to extrahepatic tissues in rats. J Nutr (2002) 0.83
Purification, characterization, and expression of rat intestinal alkaline sphingomyelinase. J Lipid Res (2002) 0.82
Ursolic acid inhibits acid sphingomyelinase in intestinal cells. Phytother Res (2012) 0.81
Acid sphingomyelinase is induced by butyrate but does not initiate the anticancer effect of butyrate in HT29 and HepG2 cells. J Lipid Res (2005) 0.81
Rat intestinal ceramidase: purification, properties, and physiological relevance. Am J Physiol Gastrointest Liver Physiol (2004) 0.81
Ezetimibe inhibits expression of acid sphingomyelinase in liver and intestine. Lipids (2009) 0.81
Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells. Cancer Lett (2005) 0.81
Symptoms and immunologic markers among vulcanization workers in rubber industries in southern Sweden. Scand J Work Environ Health (2007) 0.81
Reduction in alkaline sphingomyelinase in colorectal tumorigenesis is not related to the APC gene mutation. Int J Colorectal Dis (2003) 0.80
Cloning of alkaline sphingomyelinase from rat intestinal mucosa and adjusting of the hypothetical protein XP_221184 in GenBank. Biochim Biophys Acta (2005) 0.80
Psyllium and fat in diets differentially affect the activities and expressions of colonic sphingomyelinases and caspase in mice. Br J Nutr (2004) 0.80
Antiproliferative effects of curcuphenol, a sesquiterpene phenol. Fitoterapia (2010) 0.79
Boswellic acid inhibits expression of acid sphingomyelinase in intestinal cells. Lipids Health Dis (2009) 0.78
Effects of fat, beef and fiber in diets on activities of sphingomyelinase, ceramidase and caspase-3 in rat colonic mucosa. Med Princ Pract (2002) 0.78
Human meconium contains significant amounts of alkaline sphingomyelinase, neutral ceramidase, and sphingolipid metabolites. Pediatr Res (2007) 0.78
Multiple anticancer effects of damsin and coronopilin isolated from Ambrosia arborescens on cell cultures. Anticancer Res (2013) 0.78
Expression of intestinal and lung alkaline sphingomyelinase and neutral ceramidase in cystic fibrosis f508del transgenic mice. J Pediatr Gastroenterol Nutr (2008) 0.77
Development of intestinal alkaline sphingomyelinase in rat fetus and newborn rat. Lipids (2003) 0.77
In vitro effects of fat, FA, and cholesterol on sphingomyelin hydrolysis induced by rat intestinal alkaline sphingomyelinase. Lipids (2002) 0.77
Association of prothrombin and protein S with plasma triglyceride-rich lipoproteins in humans after test meals rich in milk fat or soybean oil. Thromb Res (2002) 0.77
Hepatic cirrhosis increases sensitivity of kidney to endotoxin in rats. Med Sci Monit (2002) 0.77
Estimating the limiting reducing power of SmI2/H2O/amine and YbI2/H2O/amine by efficient reduction of unsaturated hydrocarbons. J Org Chem (2006) 0.77
Dietary sphingomyelin inhibits colonic tumorigenesis with an up-regulation of alkaline sphingomyelinase expression in ICR mice. Anticancer Res (2009) 0.76
Lycopene suppresses proinflammatory response in lipopolysaccharide-stimulated macrophages by inhibiting ROS-induced trafficking of TLR4 to lipid raft-like domains. J Nutr Biochem (2012) 0.76
Sulindac induces apoptosis, inhibits proliferation and activates caspase-3 in Hep G2 cells. Anticancer Res (2002) 0.76
Thrombotic occlusion of all left coronary branches in a young woman with severe ulcerative colitis. ISRN Cardiol (2011) 0.75
Changes of activity and isoforms of alkaline sphingomyelinase (nucleotide pyrophosphatase phosphodiesterase 7) in bile from patients undergoing endoscopic retrograde cholangiopancreatography. BMC Gastroenterol (2014) 0.75
[Management of severe attack of ulcerative colitis]. Lakartidningen (2009) 0.75
Solubilization of sphingomyelin vesicles by addition of a bile salt. Chem Phys Lipids (2007) 0.75
[Sporadic colorectal polyps. Updated guidelines for endoscopic surveillance]. Lakartidningen (2003) 0.75
[The researcher, the society and partiality]. Lakartidningen (2008) 0.75
High levels of vitamin D associated with less ischemic heart disease - a nested case-control study among rural men in Sweden. Ann Agric Environ Med (2017) 0.75